Shares of Johnson Matthey PLC (LON:JMAT – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six analysts that are currently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is GBX 2,218.33.
A number of equities research analysts have commented on JMAT shares. Berenberg Bank decreased their price objective on Johnson Matthey from GBX 2,250 to GBX 2,100 and set a “buy” rating for the company in a research report on Monday, March 23rd. Deutsche Bank Aktiengesellschaft raised their price objective on Johnson Matthey from GBX 1,922 to GBX 2,120 and gave the stock a “buy” rating in a research report on Tuesday, April 7th. Finally, UBS Group reaffirmed a “neutral” rating and set a GBX 2,200 price target on shares of Johnson Matthey in a research note on Friday, May 22nd.
View Our Latest Research Report on JMAT
Insider Transactions at Johnson Matthey
Johnson Matthey Stock Performance
Shares of Johnson Matthey stock opened at GBX 2,116 on Friday. Johnson Matthey has a 12 month low of GBX 1,660 and a 12 month high of GBX 2,434. The stock has a market cap of £3.55 billion, a PE ratio of -32.11, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.91. The company has a quick ratio of 0.76, a current ratio of 1.65 and a debt-to-equity ratio of 71.01. The business has a fifty day simple moving average of GBX 2,026.14 and a 200-day simple moving average of GBX 2,107.52.
Johnson Matthey (LON:JMAT – Get Free Report) last announced its quarterly earnings data on Thursday, May 28th. The company reported GBX 128.50 EPS for the quarter. Johnson Matthey had a negative return on equity of 5.87% and a negative net margin of 1.13%.The firm had revenue of GBX 1,257.30 billion during the quarter. On average, sell-side analysts anticipate that Johnson Matthey will post 173.4112903 EPS for the current fiscal year.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Further Reading
- Five stocks we like better than Johnson Matthey
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
